By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Pepiniere Sante Cochin
29 rue du Faubourg Saint Jacques
Paris    75014  France
Phone: 01-55-426200 Fax: 01-55-426201


Company News
PHARNEXT Amends The Protocol Of The International Pivotal Phase III Trials Of PXT3003 For Charcot-Marie-Tooth Disease Type 1A 9/19/2017 7:22:10 AM
PHARNEXT’s PXT3003 Featured At The American Association Of Neuromuscular & Electrodiagnostic Medicine (AANEM) 2017 Annual Meeting 9/8/2017 7:19:00 AM
PHARNEXT To Present At Rodman & Renshaw 19th Annual Global Investment Conference 9/6/2017 12:32:12 PM
PHARNEXT Announces That The DSMB Recommends Continuing The Ongoing Phase III Trial Of PXT3003 For Charcot-Marie-Tooth Disease Type 1A 9/6/2017 11:15:56 AM
PHARNEXT To Present PXT864 Data At The Alzheimer's Association International Conference 2017 7/11/2017 7:41:41 AM
PHARNEXT’s PLEODRUG, PXT3003, To Be Featured In Multiple Presentations At The 2017 Peripheral Nerve Society Meeting 6/28/2017 7:12:53 AM
PHARNEXT To Showcase Pioneering PLEOTHERAPY R&D Platform At 6th Annual Drug Repositioning, Repurposing And Rescue Conference 6/21/2017 7:04:31 AM
PHARNEXT Announces Strategic Partnership With Tasly Pharmaceutical, A Leading Chinese Pharmaceutical Group 5/10/2017 6:46:50 AM
PHARNEXT Reports Year End 2016 Financial Results 4/26/2017 11:28:44 AM
PHARNEXT Announces Reclassification Of Its Historical Investor’s Shares, Strengthening The Position Of Core Shareholders 3/29/2017 10:34:27 AM